“Malignant” Perivascular Epithelioid Cell Neoplasm: Risk Stratification and Treatment Strategies
Open Access
- 1 January 2012
- journal article
- review article
- Published by Hindawi Limited in Sarcoma
- Vol. 2012, 1-12
- https://doi.org/10.1155/2012/541626
Abstract
Purpose. Perivascular epithelioid cell tumors (PEComas) are a rare collection of tumors characterized by a myomelanocytic phenotype, and PEComas occurring in “nonclassic” anatomic distributions are known as perivascular epithelioid cell tumor not otherwise specified (PEComa-NOS). This review aims to compile and analyze cases of PEComa-NOS in an effort to better define their natural history.Design. We evaluated all 234 cases of PEComa-NOS reported in the English literature, extracting information regarding diagnostic features, treatment approaches, and outcomes. Multivariate analysis of a number of variables evaluable on pathologic review was performed to refine preexisting risk stratification criteria. Outcomes for patients receiving nonsurgical treatment are also reported.Results. Primary tumor size ≥5 cm () and a high (1/50 HPF) mitotic rate () were the only factors significantly associated with recurrence following surgical resection. Cytotoxic chemotherapy and radiation therapy have shown little benefit in treating PEComa-NOS; mTOR inhibition is emerging as a treatment option.Conclusion. Progress has been made in understanding the natural history and molecular biology of PEComa-NOS. This review further clarifies risk of recurrence in this disease, allowing clinicians to better risk stratify patients. Further work should focus on applying this knowledge to making treatment decisions for patients with this disease.
Keywords
Funding Information
- National Center for Research Resources (UL1 RR024150)
This publication has 84 references indexed in Scilit:
- PEComa Presenting in Bone: Clinicopathologic Analysis of 6 Cases and Literature ReviewThe American Journal of Surgical Pathology, 2010
- The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2Molecular and Cellular Biology, 2008
- The TSC1–TSC2 complex: a molecular switchboard controlling cell growthBiochemical Journal, 2008
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or LymphangioleiomyomatosisThe New England Journal of Medicine, 2008
- PEComa of the Upper Extremity: A Unique Case and Description of an Initial Response to Neoadjuvant ChemotherapySarcoma, 2007
- Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasmsHuman Pathology, 2007
- Malignant perivascular epithelioid cell tumor (PEComa) of the uterus with late renal and pulmonary metastases: a case report with review of the literatureDiagnostic Pathology, 2007
- Perivascular Epithelioid Cell Tumor of the Orbit: A Case Report and Review of the LiteraturePediatric and Developmental Pathology, 2005
- An epidemiological study of renal pathology in tuberous sclerosis complexBJU International, 2004
- High Frequency of Pulmonary Lymphangioleiomyomatosis in Women With Tuberous Sclerosis ComplexMayo Clinic Proceedings, 2000